| 1. | | Recruiting | 3-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome
Conditions: acute leukemia; adult acute monoblastic and acute monocytic leukemia; atypical chronic myeloid leukemia; chronic leukemia; ... |
| 2. | | No longer recruiting | Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ... |
| 3. | | Recruiting | Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment
Conditions: adult solid tumor; Leukemia; Lymphoma; small intestine cancer |
| 4. | | Recruiting | Benzoylphenylurea in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 5. | | No longer recruiting | Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 6. | | No longer recruiting | Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer
Conditions: stage I prostate cancer; stage II prostate cancer; adenocarcinoma of the prostate |
| 7. | | No longer recruiting | Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus
Condition: Esophageal Cancer |
| 8. | | Recruiting | Chemotherapy Plus Sargramostim in Treating Patients With Refractory Myeloid Cancer
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ... |
| 9. | | No longer recruiting | Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma |
| 10. | | Completed | Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer
Conditions: childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases |
| 11. | | Recruiting | Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 12. | | Recruiting | Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
Conditions: Male Breast Cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer; recurrent breast cancer |
| 13. | | Recruiting | Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Colorectal Cancer
Conditions: Colon Cancer; Rectal Cancer |
| 14. | | Recruiting | Erlotinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Mouth or Throat Cancer
Conditions: stage II squamous cell carcinoma of the lip and oral cavity; stage II squamous cell carcinoma of the oropharynx; ... |
| 15. | | Recruiting | Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer, Ovarian Cancer, or Squamous Cell Carcinoma of the Head and Neck
Conditions: Drug Toxicity; female reproductive cancer; Head and Neck Cancer; thorax and respiratory cancer |
| 16. | | Recruiting | Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Acute Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 17. | | No longer recruiting | Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
Condition: Lymphoma |
| 18. | | Recruiting | Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
Conditions: Bladder Cancer; stage 0 bladder cancer; stage I bladder cancer; transitional cell carcinoma of the bladder |
| 19. | | Recruiting | Monoclonal Antibody Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
Conditions: adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma |
| 20. | | Recruiting | MS-275 in Treating Patients With Hematologic Cancer
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; myelodysplastic and myeloproliferative disease; plasma cell neoplasm |
| 21. | | Recruiting | Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer
Conditions: stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer |
| 22. | | Recruiting | Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; ... |
| 23. | | No longer recruiting | Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
Conditions: Leukemia; Lymphoma; Plasma Cell Neoplasm; Aplastic Anemia; Solid Tumor; Graft Versus Host Disease |
| 24. | | Completed | Procarbazine in Treating Patients With Recurrent Brain Tumor
Conditions: Brain Tumor; Oligodendroglioma; Glioblastoma; Astrocytoma |
| 25. | | Completed | Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma
Conditions: ciliary body and choroid melanoma, medium/large size; Stage IV Melanoma; extraocular extension melanoma; recurrent intraocular melanoma; ... |
| 26. | | Recruiting | Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome
Conditions: atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; myelodysplastic and myeloproliferative disease; Myelodysplastic Syndromes |
| 27. | | Recruiting | Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia
Conditions: relapsing chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ... |
| 28. | | Recruiting | Screening For Early Pancreatic Neoplasia in Individuals With Familial Peutz-Jeghers Syndrome and in Relatives of Individuals With Familial Pancreatic Cancer
Condition: Pancreatic Cancer |
| 29. | | Suspended | Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 30. | | Recruiting | Tipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndromes |
| 31. | | Recruiting | UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors
Condition: unspecified adult solid tumor, protocol specific |
| 32. | | Recruiting | Vaccine Therapy Combined With Adjuvant Chemoradiotherapy in Treating Patients With Resected Stage I, Stage II, or Stage III Adenocarcinoma (Cancer) of the Pancreas
Conditions: stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; duct cell adenocarcinoma of the pancreas |
| 33. | | Recruiting | Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
Conditions: stage IV breast cancer; recurrent breast cancer |
